Recombinant Danio rerio Neurogenic differentiation factor 1 (neurod1)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult local distributors for specifics. Proteins are shipped with blue ice packs by default. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Default glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us.
Synonyms
neurod1; neurod; nrdNeurogenic differentiation factor 1; NeuroD; NeuroD1
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-350
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Danio rerio (Zebrafish) (Brachydanio rerio)
Target Names
Target Protein Sequence
MTKSYSEESM MLESQSSSNW TDKCHSSSQD ERDVDKTSEP MLNDMEDDDD AGLNRLEDED DEEEEEEEED GDDTKPKRRG PKKKKMTKAR MQRFKMRRMK ANARERNRMH GLNDALESLR KVVPCYSKTQ KLSKIETLRL AKNYIWALSE ILRSGKSPDL MSFVQALCKG LSQPTTNLVA GCLQLNPRTF LPEQSQEMPP HMQTASASFS ALPYSYQTPG LPSPPYGTMD SSHIFHVKPH AYGSALEPFF DTTLTDCTSP SFDGPLSPPL SVNGNFSFKH EPSSEFEKNY AFTMHYQAAG LAGAQGHAAS LYAGSTQRCD IPMENIMSYD GHSHHERVMN AQLNAIFHDS
Uniprot No.

Target Background

Function
Potential transcriptional activator. Differentiation factor necessary for neurogenesis. Activates isl1.
Gene References Into Functions
Neurod's roles include: 1. Governing photoreceptor genesis (PMID: 26580854) 2. Generating endocrine pancreas subtypes (PMID: 25797153) 3. Circadian clock function in photoreceptors (PMID: 24924194) 4. Activating NeuroD1 with Nkx2.2 (PMID: 19759004) 5. Endocrine cell fate determination with Ascl1b (PMID: 23835295) 6. Determining posterior lateral line neuron subtypes (PMID: 23303935) 7. Non-ventricular neurogenesis in zebrafish forebrain (PMID: 12204253) 8. Hair cell differentiation with atonal homolog 1 (PMID: 16678150) 9. Photoreceptor genesis and maturation with Crx (PMID: 17206615) 10. Regulating cell cycle withdrawal in photoreceptor genesis (PMID: 19121642)
Database Links

KEGG: dre:30169

STRING: 7955.ENSDARP00000026490

UniGene: Dr.75801

Subcellular Location
Cytoplasm. Nucleus.
Tissue Specificity
In the embryo, expressed broadly in a subset of primary neurons in the brain and spinal cord. At 28 hours post-fertilization (hpf), regions of expression include telencephalon, olfactory placode, epiphysis, cranial ganglia, acoustic ganglia, Rohon-Beard m

Q&A

Advanced Research Questions

  • What methodological approaches are most effective for studying neurod1 function in zebrafish?

Investigating neurod1 function in zebrafish requires a multi-faceted approach combining genetic, molecular, and imaging techniques:

Genetic Manipulation Strategies:

  • Conditional systems: The neurod1-2A-Cre driver system enables precise temporal and spatial gene manipulation in neurod1-expressing cells. This approach has successfully demonstrated conditional rescue of rb1 function specifically in neurod1-expressing progenitors, resulting in significant changes in proliferation markers in the midbrain (p<0.05) and retina (p<0.01) .

  • CRISPR/Cas9 genome editing: For generating neurod1 mutations or knock-in reporters

  • Morpholino knockdown: For transient loss-of-function studies during early development

Molecular Techniques:

  • ChIP-seq analysis: To identify genome-wide neurod1 binding sites

  • RNA-seq following neurod1 manipulation: To characterize downstream transcriptional networks

  • In vivo reporter assays: Using E-box containing promoters to assess neurod1 activity

Imaging Methods:

  • Time-lapse confocal microscopy: To track neurod1-expressing cells during development

  • Immunohistochemistry with neuronal markers: To assess differentiation status

  • EdU/BrdU incorporation assays: To analyze cell cycle dynamics in neurod1+ cells

Research has demonstrated that Cre-mediated recombination in neurod1-expressing cells can achieve >34% inversion rates of conditional alleles, sufficient to observe significant phenotypic changes in targeted tissues . This underscores the effectiveness of conditional approaches for studying neurod1 function in specific developmental contexts.

  • How can researchers design and implement neurod1-driven conditional gene expression systems?

Designing effective neurod1-driven conditional systems requires careful consideration of several key components:

System Components and Design:

  • Promoter selection: The neurod1 promoter fragment must accurately recapitulate endogenous neurod1 expression. Research has successfully utilized neurod1-2A-Cre constructs that specifically target neuronal progenitors in the developing brain and retina .

  • Recombination strategy: The Cre/lox system allows for conditional gene activation or inactivation. For example:

    • UFlip cassette design enables inversion-based conditional rescue

    • loxP-flanked target genes allow for tissue-specific deletion

  • Validation reporters: Include fluorescent markers (e.g., gcry1:GFP) to track expression and recombination events .

Implementation Protocol:

  • Generate neurod1-2A-Cre driver line using Tol2 transposition

  • Create conditional target alleles (e.g., "on" and "off" configurations)

  • Cross driver and conditional lines to generate experimental genotypes

  • Analyze recombination efficiency using PCR junction analysis

  • Assess phenotypic outcomes using appropriate tissue-specific assays

Quantification Methods:

  • Junction PCR analysis: To confirm cassette inversion at the DNA level

  • Genomic qPCR: To quantify recombination efficiency (>34% inversion is sufficient for observable phenotypes)

  • Immunostaining: To assess phenotypic markers (e.g., pH3 for proliferation)

Research using neurod1-2A-Cre drivers has successfully demonstrated conditional rescue and inactivation of genes like rb1, highlighting the utility of this approach for investigating gene function specifically in neurod1-expressing neuronal progenitors .

  • What are the challenges and solutions for optimizing neurod1-Cre recombination efficiency?

Achieving optimal neurod1-Cre recombination efficiency presents several challenges that researchers should address systematically:

Common Challenges:

ChallengePotential CausesSolutions
Low recombination efficiencyWeak promoter activityUse extended neurod1 promoter with all enhancers
Poor Cre expressionOptimize codon usage; include WPRE element
Inaccessible lox sitesTest alternative genomic integration sites
Mosaic expressionTransgene silencingScreen multiple F1 founders for consistent expression
Position effectsUse insulator sequences to buffer integration site effects
ToxicityExcessive Cre activityUse CreERT2 for inducible control

Optimization Strategies from Research:

  • Delivery method comparison: Direct Cre mRNA injection achieves higher recombination rates (>80%) compared to transgenic drivers (typically 25-35%)

  • Quantification approaches: Genomic qPCR of junction fragments provides accurate measurement of recombination efficiency

  • Validation methods: Always confirm recombination through both molecular (PCR) and phenotypic (functional) analyses

Research has demonstrated that even partial recombination (>25% inversion) in neurod1-expressing cells is sufficient to induce significant phenotypic changes, such as altered cell proliferation in the developing brain and retina . This suggests that careful optimization can yield biologically meaningful results even without achieving complete recombination.

  • How does neurod1 interact with cell cycle regulators during neuronal differentiation?

Neurod1 coordinates neuronal differentiation with cell cycle regulation through interactions with key cell cycle regulators:

Neurod1-Cell Cycle Regulatory Interactions:

Research using neurod1-2A-Cre conditional systems has revealed critical interactions between neurod1-expressing cells and the cell cycle regulator Rb1:

  • Conditional rescue experiments: When rb1 function was conditionally restored in neurod1-expressing cells, researchers observed significant reduction in pH3-positive cells in the midbrain (p<0.05) and retina (p<0.01) . This demonstrates that:

    • Neurod1-expressing progenitors require functional Rb1 for proper cell cycle regulation

    • The differentiation program driven by neurod1 is coordinated with cell cycle exit mechanisms

  • Conditional inactivation: Conversely, when rb1 was conditionally inactivated in neurod1+ cells, a significant increase in proliferation markers was observed , indicating that:

    • Rb1 functions as a critical mediator of cell cycle exit in neurod1+ neuronal progenitors

    • Neurod1's differentiation program requires proper cell cycle regulation

  • Mechanistic pathway: These findings suggest a model where:

    • Neurod1 activates transcription of neuronal differentiation genes

    • Simultaneously, neurod1 influences the activity of Rb1 to promote cell cycle exit

    • This coordination ensures that differentiating neurons exit the cell cycle at appropriate times

These interactions highlight the complex regulatory networks through which neurod1 orchestrates the transition from proliferating progenitor to differentiating neuron during zebrafish neural development.

  • What techniques are most effective for analyzing transcriptional networks downstream of neurod1?

Elucidating the transcriptional networks regulated by neurod1 requires an integrated multi-omics approach:

Comprehensive Analysis Strategy:

  • Genomic Binding Identification:

    • ChIP-seq with anti-neurod1 antibodies: Maps genome-wide binding sites

    • CUT&RUN or CUT&Tag: Provides higher resolution with fewer cells

    • ATAC-seq in neurod1+ vs. neurod1- cells: Identifies open chromatin regions potentially regulated by neurod1

  • Transcriptome Analysis:

    • RNA-seq comparing wildtype vs. neurod1 mutants: Identifies differentially expressed genes

    • Single-cell RNA-seq of neurod1+ lineages: Reveals heterogeneity and differentiation trajectories

    • Time-course analysis: Captures immediate vs. delayed transcriptional responses

  • Functional Validation:

    • Conditional manipulation using neurod1-2A-Cre systems to validate target genes

    • E-box reporter assays to confirm direct transcriptional regulation

    • CRISPR screening of candidate target genes to identify essential network components

Data Integration Framework:

Data TypeAnalysis MethodExpected Insight
ChIP-seq + RNA-seqCorrelation analysisDirect vs. indirect targets
ATAC-seq + motif analysisTranscription factor cooperativityCo-regulatory partners
scRNA-seq + trajectory analysisPseudotime orderingTemporal gene regulation cascade

Research on related transcription factors has demonstrated that such integrated approaches can effectively identify genes involved in neuronal differentiation and synaptogenesis . Similar methodologies would be highly effective for mapping neurod1-regulated networks during zebrafish neural development.

  • How can recombinant neurod1 be used in functional assays to study neurogenesis?

Recombinant neurod1 protein serves as a powerful tool for functional studies of neurogenesis in various experimental contexts:

Experimental Applications:

  • In vitro DNA binding studies:

    • Electrophoretic mobility shift assays (EMSA) with E-box containing probes

    • DNA footprinting to precisely map binding sites

    • Protocol optimization: Use freshly reconstituted protein with appropriate cofactors (E12/E47)

  • Cell culture applications:

    • Treatment of neural stem/progenitor cells to induce neuronal differentiation

    • Analysis of direct target gene activation using reporter constructs

    • Time-course experiments to distinguish immediate vs. delayed responses

  • Ex vivo applications:

    • Brain slice cultures treated with cell-permeable recombinant neurod1

    • Explant cultures to examine effects on tissue architecture and cellular organization

Optimization Guidelines:

For optimal results when using recombinant neurod1 in functional assays:

  • Reconstitute in deionized sterile water to 0.1-1.0 mg/mL

  • Add glycerol to 5-50% final concentration for stability

  • Store working aliquots at 4°C for no more than one week

  • Validate activity before experiments using E-box binding assays

  • Include appropriate negative controls (heat-inactivated protein, mutant E-box sequences)

When combined with genetic approaches such as neurod1-2A-Cre conditional systems , recombinant protein studies can provide complementary insights into neurod1's immediate effects versus long-term developmental functions in neurogenesis.

  • What are the best practices for comparing zebrafish neurod1 function to mammalian models?

Translating findings between zebrafish and mammalian neurod1 systems requires careful consideration of both conserved and divergent aspects:

Comparative Framework:

  • Sequence and structural conservation:

    • The bHLH DNA-binding domain is highly conserved (>90% identity)

    • N-terminal and C-terminal regulatory regions show greater divergence

    • DNA binding specificity (E-box recognition) is preserved across species

  • Expression pattern comparison:

    • Core neuronal expression is conserved (brain, retina, cranial ganglia)

    • Both zebrafish and mammals show neurod1 expression in the developing pancreas

    • Species-specific differences exist in temporal expression dynamics

  • Functional conservation assessment:

    • Cross-species rescue experiments (e.g., human neurod1 in zebrafish mutants)

    • Comparative ChIP-seq to identify conserved vs. species-specific targets

    • Parallel conditional manipulation using equivalent cell populations

Methodological Best Practices:

ApproachAdvantageExample Application
Conserved domain swapIsolates function of specific protein regionsTest if human bHLH domain functions in zebrafish
Equivalent genetic backgroundsControls for genetic modifiersPerform manipulations in both species on matched null backgrounds
Equivalent developmental stagesAccounts for heterochronyCompare at analogous neurogenesis periods rather than absolute time
Cross-species ChIP-seq analysisIdentifies conserved regulatory elementsDefine core neurod1 targets vs. species-specific modules

Research approaches that combine zebrafish experiments with mammalian validation provide the most robust platform for translational insights. For example, conditional manipulation strategies using neurod1-Cre drivers have proven effective in both zebrafish and mammalian systems, facilitating cross-species functional comparisons.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.